Masami Ohmori

674 total citations
38 papers, 558 citations indexed

About

Masami Ohmori is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Masami Ohmori has authored 38 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Masami Ohmori's work include Cardiovascular Syncope and Autonomic Disorders (5 papers), Acute Myeloid Leukemia Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Masami Ohmori is often cited by papers focused on Cardiovascular Syncope and Autonomic Disorders (5 papers), Acute Myeloid Leukemia Research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Masami Ohmori collaborates with scholars based in Japan. Masami Ohmori's co-authors include Akio Fujimura, Kazuhiro Harada, Koichi Sugimoto, Atsuhiro Kawaguchi, Shuichi Tsuruoka, Kenichi Harada, Eiji Kobayashi, Seiichi Ohmori, Isamu Miyamori and Minoru Okuma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Masami Ohmori

38 papers receiving 526 citations

Peers

Masami Ohmori
H. Strobach Germany
Masami Ohmori
Citations per year, relative to Masami Ohmori Masami Ohmori (= 1×) peers H. Strobach

Countries citing papers authored by Masami Ohmori

Since Specialization
Citations

This map shows the geographic impact of Masami Ohmori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Ohmori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Ohmori more than expected).

Fields of papers citing papers by Masami Ohmori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Ohmori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Ohmori. The network helps show where Masami Ohmori may publish in the future.

Co-authorship network of co-authors of Masami Ohmori

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Ohmori. A scholar is included among the top collaborators of Masami Ohmori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Ohmori. Masami Ohmori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuwang, Kentaro Ushijima, Masami Ohmori, et al.. (2011). Chronopharmacology of Angiotensin II–receptor Blockers in Stroke-Prone Spontaneously Hypertensive Rats. Journal of Pharmacological Sciences. 115(2). 196–204. 9 indexed citations
2.
Sugimoto, Koichi, Masami Ohmori, Kenichi Harada, et al.. (2006). Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. European Journal of Clinical Pharmacology. 62(3). 209–215. 21 indexed citations
4.
Kawaguchi, Atsuhiro, Masami Ohmori, & Akio Fujimura. (2004). Partial protective effect of Y-27632, a Rho kinase inhibitor, against hepatic ischemia–reperfusion injury in rats. European Journal of Pharmacology. 493(1-3). 167–171. 8 indexed citations
5.
Kawaguchi, Atsuhiro, Masami Ohmori, Shuichi Tsuruoka, et al.. (2004). Drug interaction between St John's Wort and quazepam. British Journal of Clinical Pharmacology. 58(4). 403–410. 31 indexed citations
6.
Sugimoto, Koichi, Masami Ohmori, Akio Fujimura, et al.. (2004). Case report of unchanged tacrolimus clearance in a hypoxemic pediatric liver transplant recipient with hepatopulmonary syndrome. Transplant International. 17(10). 643–646. 1 indexed citations
7.
Chen, Jianguang, Yoshinobu Nagasawa, Bing‐Mei Zhu, et al.. (2003). Pravastatin Prevents Arrhythmias Induced by Coronary Artery Ischemia/Reperfusion in Anesthetized Normocholesterolemic Rats. SHILAP Revista de lepidopterología. 4 indexed citations
8.
Ohmori, Masami, Masashi Arakawa, Kazuhiro Harada, et al.. (2003). Stereoselective Pharmacokinetics of Amlodipine in Elderly Hypertensive Patients. American Journal of Therapeutics. 10(1). 29–31. 11 indexed citations
9.
Chen, Jianguang, Yoshinobu Nagasawa, Bing‐Mei Zhu, et al.. (2003). Pravastatin Prevents Arrhythmias Induced by Coronary Artery Ischemia/Reperfusion in Anesthetized Normocholesterolemic Rats. Journal of Pharmacological Sciences. 93(1). 87–94. 40 indexed citations
10.
Harada, Kazuhiro, Masami Ohmori, & Akio Fujimura. (2002). Vasoconstricting Effect of Angiotensin II in Human Hand Veins: Influence of Aging, Diabetes Mellitus and Hypertension.. Hypertension Research. 25(5). 683–688. 5 indexed citations
11.
Ohmori, Masami, et al.. (2002). Severe low back pain due to retroperitoneal abscess formation in diabetic patients. The Brazilian Journal of Infectious Diseases. 6(6). 309–12. 2 indexed citations
12.
Arakawa, Masashi, Masato Sasaki, Masami Ohmori, Kazuhiro Harada, & Akio Fujimura. (2001). Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients. European Journal of Clinical Pharmacology. 56(11). 775–779. 13 indexed citations
13.
Kawaguchi, Atsuhiro, et al.. (2000). The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. European Journal of Pharmacology. 403(3). 203–208. 37 indexed citations
14.
Harada, Kazuhiro, Atsuhiro Kawaguchi, Masami Ohmori, & Akio Fujimura. (2000). Influence of Losartan on α-Adrenoceptor-Mediated Vasoconstrictor Response in Humans. Journal of Cardiovascular Pharmacology. 36(1). 45–49. 1 indexed citations
15.
Kawahito, Koji, Eiji Kobayashi, Masami Ohmori, et al.. (2000). Enhanced Responsiveness of Circulatory Neutrophils After Cardiopulmonary Bypass: Increased Aggregability and Superoxide Producing Capacity. Artificial Organs. 24(1). 37–42. 45 indexed citations
16.
Harada, Kazuhiro, et al.. (1999). ANGIOTENSIN II IN HUMAN VEINS: DEVELOPMENT OF RAPID DESENSITIZATION AND EFFECT OF INDOMETHACIN. Clinical and Experimental Pharmacology and Physiology. 26(12). 959–963. 7 indexed citations
17.
Harada, Kazuhiro, et al.. (1999). A Comparison of the Antagonistic Activities of Tamsulosin and Terazosin Against Human Vascular α1Adrenoceptors. The Japanese Journal of Pharmacology. 80(3). 209–216. 26 indexed citations
18.
Arakawa, Masashi, et al.. (1997). DAILY VARIATION IN AN INTENSITY OF KAOLIN - INDUCED WRITHING REACTION IN MICE. Life Sciences. 61(13). 1253–1259. 5 indexed citations
19.
Harada, Kazuhiro, Masami Ohmori, Akio Fujimura, & Kyoichi Ohashi. (1996). No Evidence of a Direct Venodilatory Effect of Furosemide in Healthy Human Subjects. The Journal of Clinical Pharmacology. 36(3). 271–273. 4 indexed citations
20.
Ohmori, Masami, Seiichi Ohmori, Yasunori Ueda, et al.. (1990). Myelodysplastic syndrome (MDS)‐associated inhibitory activity on haemopoietic progenitor cells. British Journal of Haematology. 74(2). 179–184. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026